vs
Side-by-side financial comparison of OCULAR THERAPEUTIX, INC (OCUL) and SIFCO INDUSTRIES INC (SIF). Click either name above to swap in a different company.
SIFCO INDUSTRIES INC is the larger business by last-quarter revenue ($24.0M vs $13.3M, roughly 1.8× OCULAR THERAPEUTIX, INC). SIFCO INDUSTRIES INC runs the higher net margin — 7.5% vs -488.0%, a 495.4% gap on every dollar of revenue. On growth, SIFCO INDUSTRIES INC posted the faster year-over-year revenue change (14.8% vs -22.4%). SIFCO INDUSTRIES INC produced more free cash flow last quarter ($8.0M vs $-57.1M). Over the past eight quarters, SIFCO INDUSTRIES INC's revenue compounded faster (8.1% CAGR vs -5.3%).
Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.
SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.
OCUL vs SIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $24.0M |
| Net Profit | $-64.7M | $1.8M |
| Gross Margin | 88.0% | 21.6% |
| Operating Margin | -526.5% | 10.7% |
| Net Margin | -488.0% | 7.5% |
| Revenue YoY | -22.4% | 14.8% |
| Net Profit YoY | -33.6% | 177.3% |
| EPS (diluted) | $-0.27 | $0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $24.0M | ||
| Q3 25 | $14.5M | $22.8M | ||
| Q2 25 | $13.5M | $22.1M | ||
| Q1 25 | $10.7M | $19.0M | ||
| Q4 24 | $17.1M | $20.9M | ||
| Q3 24 | $15.4M | $21.7M | ||
| Q2 24 | $16.4M | $22.0M | ||
| Q1 24 | $14.8M | $20.5M |
| Q4 25 | $-64.7M | $1.8M | ||
| Q3 25 | $-69.4M | $-429.0K | ||
| Q2 25 | $-67.8M | $3.4M | ||
| Q1 25 | $-64.1M | $-1.4M | ||
| Q4 24 | $-48.4M | $-2.3M | ||
| Q3 24 | $-36.5M | $-443.0K | ||
| Q2 24 | $-43.8M | $72.0K | ||
| Q1 24 | $-64.8M | $-1.6M |
| Q4 25 | 88.0% | 21.6% | ||
| Q3 25 | 87.8% | 9.6% | ||
| Q2 25 | 85.6% | 26.7% | ||
| Q1 25 | 88.2% | 8.3% | ||
| Q4 24 | 92.8% | 4.4% | ||
| Q3 24 | 89.9% | 10.7% | ||
| Q2 24 | 90.8% | 12.3% | ||
| Q1 24 | 91.0% | 7.3% |
| Q4 25 | -526.5% | 10.7% | ||
| Q3 25 | -472.3% | -1.7% | ||
| Q2 25 | -502.6% | 14.8% | ||
| Q1 25 | -597.5% | -4.1% | ||
| Q4 24 | -296.1% | -9.2% | ||
| Q3 24 | -298.2% | -1.5% | ||
| Q2 24 | -265.1% | 0.7% | ||
| Q1 24 | -214.0% | -6.5% |
| Q4 25 | -488.0% | 7.5% | ||
| Q3 25 | -477.3% | -1.9% | ||
| Q2 25 | -503.9% | 15.4% | ||
| Q1 25 | -598.7% | -7.3% | ||
| Q4 24 | -283.3% | -11.1% | ||
| Q3 24 | -236.6% | -2.0% | ||
| Q2 24 | -266.3% | 0.3% | ||
| Q1 24 | -438.9% | -7.8% |
| Q4 25 | $-0.27 | $0.29 | ||
| Q3 25 | $-0.38 | $-0.07 | ||
| Q2 25 | $-0.39 | $0.56 | ||
| Q1 25 | $-0.38 | $-0.23 | ||
| Q4 24 | $-0.25 | $-0.38 | ||
| Q3 24 | $-0.22 | $-0.07 | ||
| Q2 24 | $-0.26 | $0.01 | ||
| Q1 24 | $-0.49 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $737.1M | $1.1M |
| Total DebtLower is stronger | — | $39.0K |
| Stockholders' EquityBook value | $654.3M | $38.7M |
| Total Assets | $808.1M | $74.9M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $737.1M | $1.1M | ||
| Q3 25 | $344.8M | $491.0K | ||
| Q2 25 | $391.1M | $2.0M | ||
| Q1 25 | $349.7M | $1.9M | ||
| Q4 24 | $392.1M | $3.1M | ||
| Q3 24 | $427.2M | $1.7M | ||
| Q2 24 | $459.7M | $3.4M | ||
| Q1 24 | $482.9M | $2.5M |
| Q4 25 | — | $39.0K | ||
| Q3 25 | — | $51.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $3.6M | ||
| Q1 24 | — | $4.1M |
| Q4 25 | $654.3M | $38.7M | ||
| Q3 25 | $258.2M | $36.9M | ||
| Q2 25 | $305.9M | $35.8M | ||
| Q1 25 | $265.9M | $32.4M | ||
| Q4 24 | $315.3M | $33.7M | ||
| Q3 24 | $352.0M | $30.4M | ||
| Q2 24 | $377.7M | $29.8M | ||
| Q1 24 | $408.0M | $29.7M |
| Q4 25 | $808.1M | $74.9M | ||
| Q3 25 | $410.9M | $73.4M | ||
| Q2 25 | $451.3M | $77.3M | ||
| Q1 25 | $405.9M | $78.8M | ||
| Q4 24 | $457.9M | $81.0M | ||
| Q3 24 | $490.4M | $104.6M | ||
| Q2 24 | $517.1M | $106.3M | ||
| Q1 24 | $538.9M | $104.2M |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-54.2M | $8.1M |
| Free Cash FlowOCF − Capex | $-57.1M | $8.0M |
| FCF MarginFCF / Revenue | -430.9% | 33.3% |
| Capex IntensityCapex / Revenue | 21.4% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 4.51× |
| TTM Free Cash FlowTrailing 4 quarters | $-216.9M | $11.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-54.2M | $8.1M | ||
| Q3 25 | $-50.7M | $726.0K | ||
| Q2 25 | $-55.2M | $371.0K | ||
| Q1 25 | $-44.7M | $2.8M | ||
| Q4 24 | $-39.4M | $-3.8M | ||
| Q3 24 | $-36.6M | $857.0K | ||
| Q2 24 | $-24.8M | $382.0K | ||
| Q1 24 | $-33.9M | $-3.2M |
| Q4 25 | $-57.1M | $8.0M | ||
| Q3 25 | $-56.7M | $566.0K | ||
| Q2 25 | $-56.5M | $310.0K | ||
| Q1 25 | $-46.6M | $2.7M | ||
| Q4 24 | $-39.6M | $-3.9M | ||
| Q3 24 | $-36.6M | $580.0K | ||
| Q2 24 | $-25.5M | $-175.0K | ||
| Q1 24 | $-34.1M | $-3.9M |
| Q4 25 | -430.9% | 33.3% | ||
| Q3 25 | -390.0% | 2.5% | ||
| Q2 25 | -419.7% | 1.4% | ||
| Q1 25 | -435.6% | 14.1% | ||
| Q4 24 | -232.0% | -18.8% | ||
| Q3 24 | -237.6% | 2.7% | ||
| Q2 24 | -155.4% | -0.8% | ||
| Q1 24 | -231.1% | -18.9% |
| Q4 25 | 21.4% | 0.4% | ||
| Q3 25 | 41.2% | 0.7% | ||
| Q2 25 | 9.3% | 0.3% | ||
| Q1 25 | 18.1% | 0.8% | ||
| Q4 24 | 1.2% | 0.5% | ||
| Q3 24 | 0.6% | 1.3% | ||
| Q2 24 | 4.5% | 2.5% | ||
| Q1 24 | 1.7% | 3.3% |
| Q4 25 | — | 4.51× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.31× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OCUL
Segment breakdown not available.
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |
